Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Qiang Gao, Hongwen Zhu, Liangqing Dong, et al.
Cell (2019) Vol. 179, Iss. 2, pp. 561-577.e22
Open Access | Times Cited: 809

Showing 1-25 of 809 citing articles:

Evolving therapeutic landscape of advanced hepatocellular carcinoma
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 442
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
Diyang Xie, Zhenggang Ren, Jian Zhou, et al.
HepatoBiliary Surgery and Nutrition (2020) Vol. 9, Iss. 4, pp. 452-463
Open Access | Times Cited: 381
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Josep M. Llovet, Augusto Villanueva, Jorge A. Marrero, et al.
Hepatology (2020) Vol. 73, Iss. S1, pp. 158-191
Open Access | Times Cited: 322
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
Qing Li, Yong Ni, Liren Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 284
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
Yi‐Ju Chen, Theodoros I. Roumeliotis, Ya-Hsuan Chang, et al.
Cell (2020) Vol. 182, Iss. 1, pp. 226-244.e17
Open Access | Times Cited: 274
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
Zijian Yang, Cong Yan, Jiaqiang Ma, et al.
Nature Metabolism (2023) Vol. 5, Iss. 1, pp. 61-79
Closed Access | Times Cited: 273
WNT/β-catenin signaling in the development of liver cancers
Shuai He, Shilei Tang
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110851-110851
Open Access | Times Cited: 266
Recent advances in mass spectrometry based clinical proteomics: applications to cancer research
Andrew Macklin, Shahbaz Khan, Thomas Kislinger
Clinical Proteomics (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 247
Changing epidemiology of hepatocellular carcinoma in Asia
Chenhao Zhang, Yifei Cheng, Shu Zhang, et al.
Liver International (2022) Vol. 42, Iss. 9, pp. 2029-2041
Closed Access | Times Cited: 241
Integrated Omics of Metastatic Colorectal Cancer
Chen Li, Yidi Sun, Guanyu Yu, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 734-747.e9
Open Access | Times Cited: 234
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Liangqing Dong, Dayun Lu, Ran Chen, et al.
Cancer Cell (2021) Vol. 40, Iss. 1, pp. 70-87.e15
Closed Access | Times Cited: 227
Artificial intelligence and machine learning in precision and genomic medicine
Sameer Quazi
Medical Oncology (2022) Vol. 39, Iss. 8
Open Access | Times Cited: 217
Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology
Chen Yang, Xiaowen Huang, Li Yan, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 3
Closed Access | Times Cited: 201
A high-stringency blueprint of the human proteome
Subash Adhikari, Edouard C. Nice, Eric W. Deutsch, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 195
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
Yang Woo Kwon, Han-Seul Jo, Sungwon Bae, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 188
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang, Qiuju Han, Huajun Zhao, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 435-450
Open Access | Times Cited: 168
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor
Guiqi Zhu, Zheng Tang, Run Huang, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 161
N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism
Yanying Wang, Jing Wang, Xiaoyu Li, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 160
Metabolism‐associated molecular classification of hepatocellular carcinoma
Chen Yang, Xiaowen Huang, Zhicheng Liu, et al.
Molecular Oncology (2020) Vol. 14, Iss. 4, pp. 896-913
Open Access | Times Cited: 156
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Xiangyuan Luo, Kongming Wu, Xingxing He
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 153
Clinical cancer immunotherapy: Current progress and prospects
Chenglong Liu, Mengxuan Yang, Daizhou Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 149
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment
Henry Rodriguez, Jean C. Zenklusen, Louis M. Staudt, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1661-1670
Open Access | Times Cited: 148
Cancer proteogenomics: current impact and future prospects
D.R. Mani, Karsten Krug, Bing Zhang, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 298-313
Closed Access | Times Cited: 148
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
Yao‐Hui Huang, Kun Cai, Pengpeng Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 146
Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways
Yiqun Zhang, Fengju Chen, Darshan S. Chandrashekar, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 145
Page 1 - Next Page

Scroll to top